Stabilized hepatitis B patients are able to receive the third shot of New Crown. The New Crown vaccine is mainly used to resist the attack of the New Crown virus and will not affect the condition and liver function of hepatitis B patients. However, the prerequisite is to ensure that the liver function of hepatitis B patients is normal, such as: transaminases, bilirubin and other key indicators are within the normal range. Patients in this stabilized stage will not cause Hepatitis B viral disease after the third dose of the New Crown vaccine. Special attention should be paid to the fact that if the condition of hepatitis B patients has been unstable recently, such as pain in the liver area, abnormal liver function, etc., then it is not suitable to receive the third injection of New Crown Vaccine at this stage. It is recommended that patients should go to a professional hospital for checkups and under the guidance of a doctor to control their hepatitis B condition first, and then inject the vaccine after their condition has stabilized.